Awarded
SUMINISTRO MEDICAMENTOS EXCLUSIVOS: SEBELIPASA ALFA (KANUMA) Y RAVULIZUMAB (ULTOMIRIS).
Track this recordFree account — get alerted when a contract here runs out.
- Winners
- ALEXION PHARMA SPAIN, S.L.
- Contract value
- €447,017
- Bids received
- 1
- Published
- 12 Jan 2026
- Awarded
- 28 Nov 2025
- Contract start
- 28 Nov 2025
- Contract end
- 29 Nov 2026estimated
- Region
- Madrid